Internationally scalable waste anaesthetic capture and recycling system

Gallery Internationally scalable waste anaesthetic capture and recycling system 1
Gallery Internationally scalable waste anaesthetic capture and recycling system 1
October 2020
Headquarters Paignton TQ4 7AU, UK
Share

Internationally scalable waste anaesthetic capture and recycling system - SageTech's technology captures and recycles environmentally damaging and expensive anaesthetic gases used extensively throughout global healthcare.

Healthcare's mission is to “first, do no harm” but has a significant climate footprint and makes a major contribution to the climate crisis, which is evolving into a global health emergency.

Volatile anaesthetic drugs are widely used with a global annual turnover of $1.3bn. The drugs are expensive to produce, in monetary and environmental terms. In practice, once exhaled by patients the drugs are vented to atmosphere. This is very damaging to the environment, contributing a huge 3.1 million tons of CO2 equivalents a year. SageTech’s solution prevents this atmospheric discharge, collects the exhaled drug, and re-purifies it, fit for human re-use. Drug metabolism is low, around 5%, so recovery yields are very high. The solution deploys a system of collection and purification that has sustainability at its core. Working with our pressure systems keeps instruments compact and no organic solvents are used in our process. SageTech’s solution offers large financial savings on hospital infrastructure installations and maintenance costs by eliminating the need for expensive air extraction systems to take the exhaled drugs from the operating theatres to the chimney.

  • /

Key features

  • Prevents release of 3.1Mt CO2-eq per year

Profitability

  • Eliminates the need for expensive air extraction systems
  • Substantial financial savings on hospital infrastructure installations and maintenance costs
  • 50% saving versus current environmental damaging infrastructure

Company Profile

Maturity Stage

  • Medium and large scale commercialization
  • Small scale commercialization
  • Initial market commercialization
  • Prototype testing in the real world
  • Prototype testing 1:1 in the lab

Looking For

Activity Region

  • /

Europe

United Kingdom,

  • Headquarters
  • Activity

The information set out above, is solely for the purposes of information and the Solar Impulse Foundation does not provide any guarantee as to its authenticity, completeness or accuracy. This information does not constitute investment advice or a recommendation to buy into, transact or to enter into any agreement with any of the parties or persons mentioned above. Potential investors or interested parties are solely responsible for their investment or business decisions and for performing any due diligence required by the circumstances.